Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chengdu Zenitar Biomedical Technology Co., Ltd
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
City of Hope Medical Center
Bio-Path Holdings, Inc.
Daiichi Sankyo
University College, London
Northwestern University